Professor of Medicine, Johns Hopkins University
HOME
ABOUT US
SCIENCE & PIPELINE
INVESTOR RELATIONS
CONTACT US
CAREERS
More
Sterotherapeutics Signs Licensing Agreement Aimed to Improve the Treatment of Multiple Myeloma
March 30, 2022
SteroTherapeutics, LLC signs CRADA Agreement with NIH to Develop a Novel Treatment for Cushing Syndrome Patients
December 2, 2020
SteroTherapeutics Receives New U.S. Patent for treatment of non-alcoholic Steatohepatitis (NASH)
March 28, 2019
SteroTherapeutics Receives FDA Orphan-Drug Designation
April 4, 2018
SteroTherapeutics Announces Closing of Financing to Accelerate Clinical Study for Non-Alcoholic Steatohepatitis (NASH)
February 27, 2018